WINTER 2015
IN THIS ISSUE
FEATURE

PHARMA TECH COMPLETES 

REBRANDING CAMPAIGN

Pharma Tech Industries has officially launched a comprehensive rebranding campaign.  Driven by the company's elevated stature in a sector that has seen increasing consolidation among CMOs, the brand refresh was the culmination of several months of customer interviews, strategic planning among the executive team and graphic exploration of a new corporate image.  The new "face" of Pharma Tech includes a re-interpretation of the company logo, the introduction of a new tagline ("We make products that fulfill promises"), a completely revamped website (www.pharma-tech.com), an interactive/print advertising campaign and new collateral materials.

  

Each of these efforts emphasize Pharma Tech's consistent compiling of new and expanded capabilities, manufacturing capacity and production space as an extension of its established reputation as a trusted turnkey CMO.  They also are inspired by what Pharma Tech identifies as its five core principles: integrity, stewardship, humility, optimism and working together.

 

Pharma Tech's proven ability to closely collaborate with customers to find creative solutions to manufacturing and packaging challenges demonstrates the brand stewardship the company has historically taken in their approach to customer satisfaction. "We work for some of the most trusted health and wellness brands in the world," explains Tee Noland, Chairman & CEO of Pharma Tech Industries.  "It's our job to meet the growing expectations of their customers on a daily basis.  Our organization is built to deliver on that promise and, given our increasing rate of employee retention and satisfaction, I am proud to say that our entire team has repeatedly delivered on this challenge."  


 

ANOTHER PHARMA COMPANY PLACES TRUST IN PHARMA TECH FOR PRODUCT DEVELOPMENT  

Pharma Tech Industries recently completed a successful Pre-Approval Inspection (PAI) with the FDA for a powder inhalation project on behalf of a key customer that will soon go to market. 

 

This PAI comes after over a year's worth of manufacturing and packaging development and optimization performed by Pharma Tech's Royston, GA operation.  This novel process will include low-dose filling of an API powder into a capsule and subsequent packaging into a patented nose piece and nasal inhaler.   The benefits of this delivery system include a faster acting API to treat patients with severe migraine disorders.

 

Pharma Tech anticipates final NDA approval by the FDA and subsequent commercial production sometime in 2015. 

COMPANY SPOTLIGHT

DENNIS KINSEY JOINS PHARMA TECH AS DIRECTOR OF BUSINESS DEVELOPMENT

Pharma Tech Industries is pleased to announce the addition of Dennis Kinsey, who has joined the company as Director of Business Development.  In his new role, Dennis will work alongside Rich Loughlin, VP of Strategic Sales, and be a major part of Pharma Tech's growth plans for the near future. 

 

An industry veteran for more than thirty years, Dennis has worked in supply chain for such companies as Johnson & Johnson, GlaxoSmithKline's Consumer Healthcare division, AstraZeneca and, most recently, Insight Pharmaceuticals.  At Insight, he worked with PTI for over 10 years on the CaldesceneĀ® powders brand as part of his 20 years of overall tenure with the company. 

 

Carl Oberg, who retired at the end of the year after 13 years of exemplary service to Pharma Tech, worked with Dennis to transition his sales and account management responsibilities. Dennis will be based in his home office near Philadelphia, PA.  

SHOWS & EVENTS

Consumer Healthcare Products Association Annual Executive Conference 

March 9-11, 2015

Hyatt Regency Coconut Point Resort & Spa

Bonita Springs, FL

Drug, Chemical & Associated Technologies (DCAT) Week 

March 16-19, 2015

New York, NY


Pharma Tech Industries | 272 West Hancock Avenue | Suite 300D | Athens | GA | 30601